Form 8-K - Current report:
SEC Accession No. 0000950170-21-004906
Filing Date
2021-11-24
Accepted
2021-11-24 16:15:49
Documents
14
Period of Report
2021-11-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aura-20211124.htm   iXBRL 8-K 53780
2 EX-99.1 aura-ex99_1.htm EX-99.1 312869
3 GRAPHIC img28679202_0.jpg GRAPHIC 4682
  Complete submission text file 0000950170-21-004906.txt   510575

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aura-20211124_pre.xml EX-101.PRE 10293
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aura-20211124.xsd EX-101.SCH 2496
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aura-20211124_lab.xml EX-101.LAB 14010
7 EXTRACTED XBRL INSTANCE DOCUMENT aura-20211124_htm.xml XML 4929
Mailing Address 85 BOLTON STREET CAMBRIDGE MA 02140
Business Address 85 BOLTON STREET CAMBRIDGE MA 02140 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40971 | Film No.: 211446892
SIC: 2836 Biological Products, (No Diagnostic Substances)